UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and Validation of a Patient-Reported Outcome Measure of the Impact of Chronic Hand Eczema on Health-Related Quality of Life: the Hand Eczema Impact Scale (HEIS)

Dermatology and therapy, 2024-10

2024

Volltextzugriff (PDF)

Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI-75 and HECSI-90 as within-patient responder definitions

Contact dermatitis, 2024-10

2024

Volltextzugriff (PDF)

Hand Eczema. Part 1: epidemiology, pathogenesis, diagnosis and work-up

Journal of the American Academy of Dermatology, 2024-10

2024

Volltextzugriff (PDF)

Hand Eczema. Part 2: Prevention, management, and treatment

Journal of the American Academy of Dermatology, 2024-10

2024

Volltextzugriff (PDF)

Hand eczema and changes in the skin microbiome after 2 weeks of topical corticosteroid treatment

Journal of the European Academy of Dermatology and Venereology, 2024-10

2024

Volltextzugriff (PDF)

52715 Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results of the Phase 3 DELTA-1 and -2 trials

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB36-AB36

2024

Volltextzugriff (PDF)

655 - Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA-3 trial

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

653 - Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results of the phase 3 DELTA-1 and -2 trials

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

Topical Corticosteroid Phobia among Danish Pharmacy Staff

Dermatology (Basel), 2024-08, Vol.240 (4), p.581-588

2024

Volltextzugriff (PDF)

Current frequency of contact allergy to isothiazolinones (methyl-, benz- and octylisothiazolinone) across Europe

Contact dermatitis, 2024-07, Vol.91 (4), p.271-277

2024

Volltextzugriff (PDF)

Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross‐sectional validation and registry‐based study

Contact dermatitis, 2024-04, Vol.90 (4), p.350-364

2024

Volltextzugriff (PDF)

Prevalence and incidence of hand eczema in healthcare workers: A systematic review and meta‐analysis

Contact dermatitis, 2024-04, Vol.90 (4), p.331-342

2024

Volltextzugriff (PDF)

Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA–CHE): a new clinician reported outcome measure of CHE severity

Archives of Dermatological Research, 2024-03, Vol.316 (4), p.110-110, Article 110

2024

Volltextzugriff (PDF)

Chronisches Handekzem in Europa: Erfassung von Patientenerfahrungen und -perspektiven (CHEPEP) anhand von qualitativen Interviews

Karger Kompass Dermatologie, 2024-02, Vol.12 (1), p.4-11

2024

Volltextzugriff (PDF)

Assessment of hand eczema severity by patients using the hand eczema severity index (HECSI)

Journal of the European Academy of Dermatology and Venereology, 2023-11, Vol.37 (11), p.2349-2354

2023

Volltextzugriff (PDF)

Erratum for Barnes et al., “Temporal and Spatial Variation of the Skin-Associated Bacteria From Healthy Participants and Atopic Dermatitis Patients”

mSphere, 2023-10, Vol.8 (5), p.e0031923-e0031923

2023

Volltextzugriff (PDF)

A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls

BMC microbiology, 2023-09, Vol.23 (1), p.1-273, Article 273

2023

Volltextzugriff (PDF)

Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial

Contact dermatitis, 2023-07, Vol.89 (1), p.46-53

2023

Volltextzugriff (PDF)

Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey

Journal of the European Academy of Dermatology and Venereology, 2023-06, Vol.37 (6), p.1199-1206

2023

Volltextzugriff (PDF)

A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis

Journal of the European Academy of Dermatology and Venereology, 2023-05, Vol.37 (5), p.1046-1055

2023

Volltextzugriff (PDF)

Treatment of chronic hand eczema with dupilumab—A retrospective follow‐up study

Journal of the European Academy of Dermatology and Venereology, 2023-04, Vol.37 (4), p.e557-e559

2023

Volltextzugriff (PDF)

Assessment of hand eczema severity: What's new?

Contact dermatitis, 2022-12, Vol.87 (6), p.556-557

2022

Volltextzugriff (PDF)

A comparison between self‐reported hand eczema and self‐reported signs and symptoms of skin lesions indicating hand eczema

Contact dermatitis, 2022-12, Vol.87 (6), p.528-534

2022

Volltextzugriff (PDF)

Altered Maturation of the Skin Microbiome in Infants with Atopic Dermatitis

Acta dermato-venereologica, 2022-11, Vol.102, p.adv00817-adv00817

2022

Volltextzugriff (PDF)

Hand eczema and temporal variation of Staphylococcus aureus clonal complexes: A prospective observational study

Journal of the American Academy of Dermatology, 2022-11, Vol.87 (5), p.1006-1013

2022

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(146)
Dänisch
(4)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Development and Validation of a Patient-Reported Outcome Measure of the Impact of Chronic Hand Eczema on Health-Related Quality of Life: the Hand Eczema Impact Scale (HEIS)

Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI-75 and HECSI-90 as within-patient responder definitions

Hand Eczema. Part 1: epidemiology, pathogenesis, diagnosis and work-up

Hand Eczema. Part 2: Prevention, management, and treatment

Hand eczema and changes in the skin microbiome after 2 weeks of topical corticosteroid treatment

52715 Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results of the Phase 3 DELTA-1 and -2 trials

655 - Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA-3 trial

653 - Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results of the phase 3 DELTA-1 and -2 trials

Topical Corticosteroid Phobia among Danish Pharmacy Staff

Current frequency of contact allergy to isothiazolinones (methyl-, benz- and octylisothiazolinone) across Europe

Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross‐sectional validation and registry‐based study

Prevalence and incidence of hand eczema in healthcare workers: A systematic review and meta‐analysis

Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA–CHE): a new clinician reported outcome measure of CHE severity

Chronisches Handekzem in Europa: Erfassung von Patientenerfahrungen und -perspektiven (CHEPEP) anhand von qualitativen Interviews

Assessment of hand eczema severity by patients using the hand eczema severity index (HECSI)

Erratum for Barnes et al., “Temporal and Spatial Variation of the Skin-Associated Bacteria From Healthy Participants and Atopic Dermatitis Patients”

A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls

Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial

Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey

A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis

Treatment of chronic hand eczema with dupilumab—A retrospective follow‐up study

Assessment of hand eczema severity: What's new?

A comparison between self‐reported hand eczema and self‐reported signs and symptoms of skin lesions indicating hand eczema

Altered Maturation of the Skin Microbiome in Infants with Atopic Dermatitis

Hand eczema and temporal variation of Staphylococcus aureus clonal complexes: A prospective observational study

Aktive Filter

Suchergebnisse filtern